>
Nanalysis Scientific logo

NSCI - Nanalysis Scientific Share Price

C$0.47 -0.0  -2.1%

Last Trade - 5:17pm

Sector
Healthcare
Size
Micro Cap
Market Cap £18.7m
Enterprise Value £19.1m
Revenue £4.61m
Position in Universe 1376th / 2703
Bullish
Bearish
Unlock NSCI Revenue
Momentum
Relative Strength (%)
1m -1.39%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -17.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 5.25 7.67 8.38 8.36 7.87 +10.7%
-94.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Nanalysis Scientific Corp revenues decreased 6% to C$7.9M.Net loss increased from C$1.2M to C$3.7M. Revenues reflectUnited States of America segment decrease of 32% to C$3.4M,Canada segment decrease of 47% to C$391K. Higher net lossreflects Salaries, benefits subcontracts increase of 83% toC$2.1M (expense), Depreciation and amortization expenseincrease from C$775K to C$1.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NSCI Revenue Unlock NSCI Revenue

Net Income

NSCI Net Income Unlock NSCI Revenue

Normalised EPS

NSCI Normalised EPS Unlock NSCI Revenue

PE Ratio Range

NSCI PE Ratio Range Unlock NSCI Revenue

Dividend Yield Range

NSCI Dividend Yield Range Unlock NSCI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NSCI EPS Forecasts Unlock NSCI Revenue
Profile Summary

Nanalysis Scientific Corp., formerly Canvass Ventures Ltd., is a Canada-based company that is engaged in the business of developing, manufacturing and selling portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The NMReady-60 is the fully-featured portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The NMReady-60 family of NMR spectrometers are used by chemical professionals in several industries including in oil and gas, chemical, pharma, biotech, food processing and also by the government and university labs.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 27, 2017
Public Since June 29, 2017
No. of Shareholders: n/a
No. of Employees: 45
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange TSX Venture Exchange
Shares in Issue 66,658,280
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NSCI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NSCI
Upcoming Events for NSCI
Wednesday 26th May, 2021
Q1 2021 Nanalysis Scientific Corp Earnings Release
Wednesday 23rd June, 2021 Estimate
Nanalysis Scientific Corp Annual Shareholders Meeting
Tuesday 29th June, 2021
Nanalysis Scientific Corp Extraordinary Shareholders Meeting
Tuesday 29th June, 2021
Nanalysis Scientific Corp Annual Shareholders Meeting
Tuesday 24th August, 2021 Estimate
Q2 2021 Nanalysis Scientific Corp Earnings Release
Frequently Asked Questions for Nanalysis Scientific
What is the Nanalysis Scientific share price?

As of 5:17pm, shares in Nanalysis Scientific are trading at C$0.47, giving the company a market capitalisation of £18.7m. This share price information is delayed by 15 minutes.

How has the Nanalysis Scientific share price performed this year?

Shares in Nanalysis Scientific are currently trading at C$0.47 and the price has moved by -2.04% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nanalysis Scientific price has moved by -24.02% over the past year.

What are the analyst and broker recommendations for Nanalysis Scientific?

There are no analysts currently covering Nanalysis Scientific.

When will Nanalysis Scientific next release its financial results?

Nanalysis Scientific is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Nanalysis Scientific dividend yield?

Nanalysis Scientific does not currently pay a dividend.

Does Nanalysis Scientific pay a dividend?

Nanalysis Scientific does not currently pay a dividend.

When does Nanalysis Scientific next pay dividends?

Nanalysis Scientific does not currently pay a dividend.

How do I buy Nanalysis Scientific shares?

To buy shares in Nanalysis Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nanalysis Scientific?

Shares in Nanalysis Scientific are currently trading at C$0.47, giving the company a market capitalisation of £18.7m.

Where are Nanalysis Scientific shares listed? Where are Nanalysis Scientific shares listed?

Here are the trading details for Nanalysis Scientific:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: NSCI
What kind of share is Nanalysis Scientific?

Based on an overall assessment of its quality, value and momentum, Nanalysis Scientific is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nanalysis Scientific share price forecast 2021?

We were not able to load any forecast data for Nanalysis Scientific.

How can I tell whether the Nanalysis Scientific share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nanalysis Scientific. Over the past six months, the relative strength of its shares against the market has been 2.19%. At the current price of C$0.47, shares in Nanalysis Scientific are trading at -0.33% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nanalysis Scientific PE Ratio?

We were not able to find PE ratio data for Nanalysis Scientific.

Who are the key directors of Nanalysis Scientific?

Nanalysis Scientific's management team is headed by:

Sean Krakiwsky - PRE
Garett Leskowitz - CSO
Luke Caplette - CFO
Greg McFeetors - OTH
Heather Phillips - OTH
Neal Gallagher - OTH
Bruce Lix - OTH
Matt Zamora - OTH
Susanne Riegel - DMK
Martin Burian - CHM
Steve Meszaros - DRC
Werner Gartner - DRC
Michal Okoniewski - DRC
Who are the major shareholders of Nanalysis Scientific?

Here are the top five shareholders of Nanalysis Scientific based on the size of their shareholding:

Krakiwsky (Sean) Individual Investor
Percentage owned: 1.75% (1.16m shares)
Okoniewski (Michal) Individual Investor
Percentage owned: 1.55% (1.03m shares)
Glass, Peter Nicholas Martin Individual Investor
Percentage owned: 1.23% (820k shares)
Gartner (Werner ) Individual Investor
Percentage owned: 1.19% (791k shares)
Burian (Martin) Individual Investor
Percentage owned: 0.82% (544k shares)
Similar to NSCI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.